{
  "success": true,
  "message": "Data fetched successfully",
  "data": {
    "_id": "663630ecd2979b16b7276f4d",
    "scheme_name": "Scheme for Promotion of Research and Innovation in Pharma MedTech (PRIP) Sector-Existing",
    "lifecycle_id": "62c4220435277c79db6165bf",
    "beneficiary_id": "663630cdd2979b16b7276cad",
    "created_at": {},
    "modified_at": {},
    "benefits": "Funding up to Rs 100 lakhs would be provided to research projects in any of the six priority areas",
    "eligibility": "1. SMEs, MSMEs, and Start-up with industry academia collaboration.\nPrevious collaboration (National / International)\nIndustrial collaboration\nAcademic collaboration\nDeveloping new products/Technology through in Make in India, Startup India, and others\n2. Availability of research talent and infrastructure\n3. Unmet needs are being solved, disease being targeted, and national health concerns\n4. Track records of patent/ citation/ research papers\n5. Possibility of generating new IP \n6. Does the technology offer import substitution/ and offer export potential",
    "conditions": "1. SMEs, MSMEs, and start-ups registered with DPIIT\n2. Potential for Employment Generation ",
    "govt_id": "62c3c60835277c79934bd90e",
    "ministry_id": "63d3bc7a35277c4edf7fc368",
    "division_id": "62c3c60935277c79934bd924",
    "scheme_id": "663630d2d2979b16b7276d44",
    "sub_scheme_id": "663630d2d2979b16b7276d56",
    "segment_id": "663630d4d2979b16b7276d82",
    "industry_id": "65c1d0589e219fedf53c402f",
    "constitution_entity_id": "65cb74aeefcca75fb33527ee",
    "msme": "Both",
    "msme_classification_id": "65c0d3fcefcca74f9b11fef6",
    "listed_unlisted_id": "62c3153d35277c4aa613ba62",
    "age_lower_limit": 0,
    "age_upper_limit": null,
    "location_id": "62c3c60b35277c79934bda1f",
    "social_category_id": "62c3153d35277c4aa613ba65",
    "gender_id": "62c3153d35277c4aa613ba67",
    "aid_type_id": "62c3c60b35277c79934bda2c",
    "beneficiaries": "1. SMEs, MSMEs, and Start-up with industry academia collaboration.\nPrevious collaboration (National / International)\nIndustrial collaboration\nAcademic collaboration\nDeveloping new products/Technology through in Make in India, Startup India, and others\n2. Availability of research talent and infrastructure\n3. Unmet needs are being solved, disease being targeted, and national health concerns\n4. Track records of patent/ citation/ research papers\n5. Possibility of generating new IP \n6. Does the technology offer import substitution/ and offer export potential",
    "prerequisites": "1. SMEs, MSMEs, and start-ups registered with DPIIT\n2. Potential for Employment Generation ",
    "program_id": "663630dfd2979b16b7276dd5",
    "nodal_agency": "Department of Pharmaceuticals",
    "who_will_claim_id": "62c3c60b35277c79934bda44",
    "context": "This Scheme is started by Ministry of Chemicals & Fertilizers, launched in 17th August 2023, for Promotion of Research and Innovation in Pharma MedTech (PRIP) Sector",
    "objective": "To encourage industry to invest in R&D in ‘Priority areas’ and to inculcate the culture of quality research and nurture the pool of scientists in the country by promoting industry-academia linkage, which will lead to sustained global competitive advantage and contribute to quality employment generation in the country.",
    "description": "Funding up to Rs 100 lakhs would be provided to research projects in any of the six priority areas to help innovators including Indian startups and MSMEs to reach TRL 4. Around 125 research projects from innovators/ start-ups/ SMEs/ MSMEs having potential or having made sufficient headway in the research of priority areas will be selected.",
    "how_to_apply": " The eligible entity shall apply through Online Portal Link-   to be given by PMA\nApplication format- https://pharmaceuticals.gov.in/sites/default/files/Approved%20Operational%20Guidelines%20%20%28PRIP%29.pdf  \nPage- 43-45",
    "funding_facilitator": "Bank",
    "funding_mechanism": "1 Project cost to be approved for R&D will be calculated post application acceptance. \n2 The funding allocated for various categories would be Rs. 125 crores \n3 The funding allocation is milestone based will be released in the following instalments: \n1st Instalment: Signing of Agreement 10% \n2nd Instalment: Completion of 1st Milestone 30% \n3rd Instalment: Completion of 2nd Milestone 30% \n4th Instalment: Completion of approved project and submission of final report 30% \nTotal 100%. Milestone achievement reviewer is PMA. Last instalment will be released after submission of project completion report. \n4 The funding allocated for one category, if left under-utilized at the end of the year can be moved to other category applicants based on their need and performance. \n5 For the proposals finally approved for funding support, PMA will sign agreement with grantees on behalf of DoP. \n6 Necessary guidance notes and templates are provided to Grantees by PMA. \n7 All grantees are required to open a separate, auditable, no-lien bank account with a scheduled commercial bank in order to receive the funds. \nBudget planning is Upgradation of Equipment/ infrastructure- 70% of Nonrecurring cost & \nFor Manpower, Consumables, Approvals, Clinical Trials, Travel, Contingencies etc., 30% of Recurring cost &\nWaivers The above guidelines shall be followed unless there is a specific exemption by DoP.",
    "highlights": "Not Applicable ",
    "status_id": "62c3153d35277c4aa613ba6b",
    "faq": "Not Applicable",
    "website": "https://pharmaceuticals.gov.in/sites/default/files/Approved%20Operational%20Guidelines%20%20%28PRIP%29.pdf",
    "additional_info": "Benefit Sharing;\n1 Beneficiaries under category B III will need to share the benefits for the successful product/technology developed through DoP’s support in either of the following ways:\na. Through 5% % benefit sharing on net sale proceeds per year of the product starting from first sale of the product/technology till 10 years; or\nb. Through 5% benefit sharing on net sale of the product till amount starting from first sale of the product/technology till the amount is equivalent to 100% of assistance received from DoP: or\nc. In the form of equity (face value of shares equivalent to 100% of the assistance provided by DoP).\n2 DoP would also seek payment in case there is transfer of intermittent technology, know-how, application to third party to further carry out commercialization with/ without further development by way of one-time transaction.\n3 Payment of benefit sharing shall fall due beginning with the first sale of the product(s) and the liability to pay benefit sharing will terminate upon the first of any of the following two events to occur:\na. Payment of 5% % benefit sharing on net sale of the product for a period of 10 years.\nb. Through 5%% benefit sharing on net sale of the product till amount is equivalent to 100% of assistance disbursed from DoP that was not returned as unutilized funds OR in the form of equity\nc. in case of Foreclosure or Termination of Project.",
    "slug": "scheme-for-promotion-of-research-and-innovation-in-pharma-medtech-(prip)-sector-existing",
    "admin_id": "676505bcf5b1a0244292dbe6",
    "status": "active",
    "custom_fields": [],
    "end_date": "31-03-2028",
    "doi_age_nyi": "AGE",
    "lower_limit": 0,
    "upper_limit": 120,
    "display_name_id": "663630e4d2979b16b7276e58",
    "is_primary": false,
    "secondary_schemes_details": "",
    "scheme_count": true,
    "category_id": "62c46c0a35277c5303055145",
    "sort": "A",
    "scheme_vertical_type": "Subsidy",
    "count": 256,
    "export": "No",
    "loan": "No",
    "maximum_loan": 0,
    "maximum_others": 100,
    "maximum_subsidy": 0,
    "start_up": "No",
    "subsidy": "No",
    "checklist_info_a": "https://pharmaceuticals.gov.in/sites/default/files/Approved%20Operational%20Guidelines%20%20%28PRIP%29.pdf",
    "checklist_info_b": "https://pharmaceuticals.gov.in/sites/default/files/Approved%20Operational%20Guidelines%20%20%28PRIP%29.pdf",
    "checklist_info_c": "Not Applicable ",
    "checklist_info_d": "Address , number & email id is availabe by referring to this link- https://pharmaceuticals.gov.in/contactus",
    "location": "All Locations",
    "social_category": "All Categories",
    "gender": "All Genders",
    "aid_type": "Incentives",
    "beneficiary": "Research Industries- Proprietorship, Partnership, Limited Liability Partnership (LLP), Private Limited Company, Public Company- All Location- MSME, All Non MSMEs",
    "lifecycle": "Required Credit Support for Scale - Up",
    "scheme_status": "Open",
    "scheme_master_name": "Scheme for Promotion of Research and Innovation in Pharma MedTech (PRIP) Sector",
    "scheme_display_name": [
      {
        "_id": "663630e4d2979b16b7276e58",
        "name": "Scheme for Promotion of Research and Innovation in Pharma MedTech (PRIP) Sector",
        "admin_id": "62c1a608bc7664d1671c8007",
        "status": "active",
        "created_at": {},
        "modified_at": {}
      }
    ],
    "display_name": "Scheme for Promotion of Research and Innovation in Pharma MedTech (PRIP) Sector"
  }
}